<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="" /><meta name="keywords" content="Withdrawal: alcohol; Alcohol: dependence; Benzodiazepines: alcohol withdrawal; Chlordiazepoxide: alcohol withdrawal; Carbamazepine: alcohol withdrawal; Clomethiazole: alcohol withdrawal; Haloperidol: alcohol withdrawal; Olanzapine: alcohol withdrawal; Acamprosate; Naltrexone: alcohol dependence; Disulfiram; Wernicke's encephalopathy; Alcohol: dependence: thiamine deficiency; Thiamine: alcohol dependence; Pancreatitis: alcohol-related" /><meta name="IX" content="Withdrawal: alcohol; Alcohol: dependence; Benzodiazepines: alcohol withdrawal; Chlordiazepoxide: alcohol withdrawal; Carbamazepine: alcohol withdrawal; Clomethiazole: alcohol withdrawal; Haloperidol: alcohol withdrawal; Olanzapine: alcohol withdrawal; Acamprosate; Naltrexone: alcohol dependence; Disulfiram; Wernicke's encephalopathy; Alcohol: dependence: thiamine deficiency; Thiamine: alcohol dependence; Pancreatitis: alcohol-related" /><title>4.10.1 Alcohol dependence: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP3177-alcohol-dependence.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP3177-alcohol-dependence.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP3177-alcohol-dependence.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 06 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP2092-central-nervous-system.htm">4 Central nervous system</a> &gt; <a href="PHP3176-drugs-used-in-substance-dependence.htm">4.10 Drugs used in substance dependence</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP3176-drugs-used-in-substance-dependence.htm" title="Previous: 4.10 Drugs used in substance dependence">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP3180-acamprosate.htm" title="Next: Acamprosate">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1><span>4.10.1 </span>Alcohol dependence</h1><?highlighter on?><div id="pC" class="jN"> <p>Excessive drinking of alcoholic beverages over a prolonged period of time can result in an alcohol withdrawal syndrome on abrupt cessation of, or marked reduction in, drinking. The presence and severity of alcohol dependence can be assessed by <em>The Severity of Alcohol Dependence Questionnaire (SADQ)</em>; other assessment questionnaires are also available. </p> <div><h2>Acute alcohol withdrawal</h2><p>People with moderate dependence can generally be treated in a community setting unless they are under 18 years of age, or are at high-risk of severe reactions or treatment failure. People with severe dependence should undergo withdrawal in an inpatient setting; withdrawal in severely dependent patients without medical support may lead to seizures, delirium tremens, and death. Long-acting benzodiazepines, usually <a title="BNF:monograph: CHLORDIAZEPOXIDE HYDROCHLORIDE" href="PHP2167-chlordiazepoxide-hydrochloride.htm"><strong>chlordiazepoxide</strong></a>, are used to attenuate alcohol withdrawal symptoms. In primary care, fixed-dose reducing regimens are usually used, whilst a symptom-triggered flexible regimen is used in hospital or other settings where continued assessment and monitoring is carried out for 24–48 hours, usually followed by a fixed 5-day reducing dose schedule (sometimes it may be necessary to continue treatment for up to 10 days). Patients with decompensated liver disease should be treated under specialist supervision.</p><p><a title="BNF:monograph: CARBAMAZEPINE" href="PHP2909-carbamazepine.htm"><strong>Carbamazepine</strong></a> [unlicensed indication] is sometimes used as an alternative treatment in acute alcohol withdrawal when benzodiazepines are contra-indicated or not tolerated. <a title="BNF:monograph: CLOMETHIAZOLE" href="PHP2138-clomethiazole.htm"><strong>Clomethiazole</strong></a> is licensed for use in acute alcohol withdrawal, but benzodiazepines are preferred. It should only be used in an inpatient setting and should not be prescribed if the patient is liable to continue drinking alcohol.</p><p>Patients with marked agitation or hallucinations and those at risk of delirium tremens (characterised by delirium, hallucinations, course tremor, and disorientation) may be prescribed antipsychotic drugs, such as <a title="BNF:monograph: HALOPERIDOL" href="PHP2226-haloperidol.htm"><strong>haloperidol</strong></a> or <a title="BNF:monograph: OLANZAPINE" href="PHP2277-olanzapine.htm"><strong>olanzapine</strong></a> [unlicensed indication], as adjunctive therapy to benzodiazepines; antipsychotics should not be used alone because they do not treat alcohol withdrawal and may lower the seizure threshold. Delirium tremens is a medical emergency that requires specialist inpatient care.</p><p>If a patient taking a benzodiazepine as part of a withdrawal regimen develops alcohol withdrawal seizures, a fast-acting benzodiazepine (such as intravenous <a title="BNF:monograph: LORAZEPAM" href="PHP3035-lorazepam.htm"><strong>lorazepam</strong></a> [unlicensed indication] or rectal <a title="BNF:monograph: DIAZEPAM" href="PHP3029-diazepam.htm"><strong>diazepam</strong></a>) should be prescribed; thereafter an increase in the dose of oral benzodiazepine should be considered to prevent further seizures from occurring.</p></div> <div><h2>Alcohol dependence</h2><p><a title="BNF:monograph-family: Acamprosate" href="PHP3180-acamprosate.htm"><strong>Acamprosate</strong></a> and <a title="BNF:monograph: NALTREXONE HYDROCHLORIDE" href="PHP3233-naltrexone-hydrochloride.htm"><strong>naltrexone</strong></a> [unlicensed indication] are effective treatments for relapse prevention in patients with alcohol dependence; <strong>disulfiram</strong> is an alternative. <a title="BNF:monograph-family: Disulfiram" href="PHP3183-disulfiram.htm">Disulfiram</a> should only be used in patients in whom acamprosate and naltrexone are not suitable, or if the patient prefers disulfiram.</p><p>Patients with alcohol dependence are at risk of developing Wernicke's encephalopathy; patients at high-risk are those who are malnourished, at risk of malnourishment, or have decompensated liver disease. Parenteral <strong>thiamine</strong> (as <em>Pabrinex</em>®, <a title="BNF:monograph: THIAMINE" href="PHP6202-thiamine.htm">section 9.6.2</a>) should be prescribed for treatment of suspected or confirmed Wernicke's encephalopathy, and for prophylaxis in alcohol-dependent patients attending hospital for acute treatment (including treatment unrelated to alcohol dependence); parenteral prophylaxis may also be considered for high-risk patients being treated in primary care. High-dose oral <a title="BNF:monograph: THIAMINE" href="PHP6202-thiamine.htm">thiamine</a> should be prescribed following parenteral treatment until cognitive function is maximised. In primary care, prophylactic high-dose oral thiamine should be prescribed during acute withdrawal of alcohol, before planned withdrawal, and for patients not undergoing withdrawal but who are at high-risk of developing Wernicke's encephalopathy.</p><p>Patients with chronic alcohol-related pancreatitis who have symptoms of steatorrhoea or who have poor nutritional status due to exocrine pancreatic insufficiency should be prescribed <strong>pancreatic enzyme supplements</strong> (<a title="BNF:sub-section: Pancreatin" href="PHP730-pancreatin.htm">section 1.9.4</a>); supplements are not indicated when pain is the only symptom.</p><p><strong>Corticosteroids</strong> (<a title="BNF:sub-section: Glucocorticoid therapy" href="PHP4331-glucocorticoid-therapy.htm">section 6.3.2</a>) are used in patients with severe acute alcohol-related hepatitis.</p></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_PHP3180-acamprosate"><a href="PHP3180-acamprosate.htm" title="Acamprosate">Acamprosate</a></li><li id="_PHP3183-disulfiram"><a href="PHP3183-disulfiram.htm" title="Disulfiram">Disulfiram</a></li><li><a href="PHP3187-naltrexone.htm" title="Naltrexone">Naltrexone</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP3176-drugs-used-in-substance-dependence.htm">Previous: 4.10 Drugs used in substance dependence</a> | <a class="top" href="PHP3177-alcohol-dependence.htm#">Top</a> | <a accesskey="]" href="PHP3180-acamprosate.htm">Next: Acamprosate</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>